Eu­ro­pean Com­mis­sion launch­es new al­liance to ad­dress crit­i­cal drug short­ages

Last year
Pharma
Manufacturing

#JPM24 re­flec­tions: No pol­i­tics, no Mi­a­mi and where the mon­ey is in biotech right now

Last year
Editor's note

Gilead can­cels bi­o­log­ics ex­pan­sion in Ocean­side, to move op­er­a­tions to Bay Area

Last year
Manufacturing

Hu­mi­ra biosim­i­lar mar­ket re­mains stag­nant, with Ab­b­Vie los­ing on­ly 2% of mar­ket share, Sam­sung re­port shows

Last year
Pharma

FDA+ roundup: Sen. Tillis goes af­ter Biden ad­min­is­tra­tion for sup­port­ing march-in rights

Last year
Pharma
FDA+

Lee’s Phar­ma to de­vel­op Windtree drug in Chi­na; Acurx shares PhI­Ib an­tibi­ot­ic da­ta; Grana­ta rais­es $14M

Last year
News Briefing

Up­dat­ed: Ven­ture cap­i­tal firm Gen­er­al Cat­a­lyst is buy­ing an Ohio-based health sys­tem

Last year
Deals
Health Tech

For­ta rais­es $55M to train fam­i­lies to be care­givers of pa­tients with chron­ic ill­ness­es

Last year
Health Tech

Dew­point Ther­a­peu­tics re­struc­tures to ‘make room’ for en­try in­to the clin­ic next year in on­col­o­gy, ALS

Last year
People
Startups

Graphite Bio co-founder de­buts Treg cell ther­a­py start­up with $75M, aims to ‘trick’ im­mune sys­tem in­to re­set­ting

Last year
Financing
Startups

Ra­tio rais­es $50M as ra­dio­phar­ma field finds its groove

Last year
Financing
Startups

Jaguar Gene Ther­a­py spins out man­u­fac­tur­ing with Deer­field, ARCH sup­port

Last year
Startups
Cell/Gene Tx

Up­dat­ed: Seagen's ADC patent de­nied by US patent of­fice in bat­tle with Dai­ichi Sankyo

Last year
Pharma
Law

Re­genxbio touts pos­i­tive mid-stage da­ta for Ab­b­Vie-part­nered vi­sion-loss gene ther­a­py, but no de­tailed plans for ...

Last year
R&D
Cell/Gene Tx

As­traZeneca reshuf­fles Chi­na lead­er­ship, sets up bio­phar­ma group to mir­ror glob­al struc­ture

Last year
People
China

Reagent mak­er Al­pha Tekno­va cuts 15% of work­ers, ter­mi­nates com­mer­cial, peo­ple ex­ec roles amid down­turn

Last year
People
Manufacturing

Co­manche se­cures $75M to test preeclamp­sia siR­NA in PhII, adds Scott Got­tlieb to board

Last year
Financing
Startups

Lon­za to shut­ter Cal­i­for­nia mam­malian clin­i­cal fa­cil­i­ty and lay off 218 staffers

Last year
People
Manufacturing

Rav­gen con­tin­ues its le­gal re­venge saga with a $57M ver­dict over Nat­era

Last year
Diagnostics
Law

Ic­ahn or­dered to re­move law­suit’s con­fi­den­tial in­for­ma­tion that was sup­plied by Il­lu­mi­na board mem­ber

Last year
Diagnostics

Scoop: Men­tal health tech uni­corn Son­der­Mind lays off 17% of its em­ploy­ees

Last year
Health Tech

Kyver­na Ther­a­peu­tics files for IPO as au­toim­mune CAR-T space heats up

Last year
Financing
Startups

On­col­o­gy drugs lead 2023 new med­i­cines in Eu­rope — EMA re­port

Last year
Pharma
FDA+

A decade af­ter its first FDA ap­proval, Take­da ex­pands la­bel of HyQvia to in­clude rare au­toim­mune dis­or­der

Last year
Pharma
FDA+
First page Previous page 216217218219220221222 Next page Last page
A service from the Financial Times